These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9234178)
21. Purging of peripheral blood stem cells yields BCR-ABL-negative autografts in patients with BCR-ABL-positive acute lymphoblastic leukemia. Martin H; Atta J; Zumpe P; Eder M; Elsner S; Rode C; Wassmann B; Bruecher J; Hoelzer D Exp Hematol; 1995 Dec; 23(14):1612-8. PubMed ID: 8542955 [TBL] [Abstract][Full Text] [Related]
22. Improvement of tumor cell depletion by combining immunomagnetic positive selection of CD34-positive hematopoietic stem cells and negative selection (purging) of tumor cells. Hoppe B; Mohr M; Roots-Weiss A; Kienast J; Berdel WE Bone Marrow Transplant; 1999 Apr; 23(8):809-17. PubMed ID: 10231144 [TBL] [Abstract][Full Text] [Related]
23. Comparison between bone marrow and G-CSF-mobilized peripheral blood allografts undergoing clinical scale CD34+ cell selection. Hassan HT; Zeller W; Stockschläder M; Krüger W; Hoffknecht MM; Zander AR Stem Cells; 1996 Jul; 14(4):419-29. PubMed ID: 8843543 [TBL] [Abstract][Full Text] [Related]
24. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems. Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119 [TBL] [Abstract][Full Text] [Related]
25. Peripheral blood stem cell rescue in children with advanced stage neuroblastoma. Kletzel M; Longino R; Danner K; Olszewski M; Moss T Prog Clin Biol Res; 1994; 389():513-9. PubMed ID: 7535461 [No Abstract] [Full Text] [Related]
26. Fate of contaminating t(14; 18)+ lymphoma cells during ex vivo expansion of CD34-selected hematopoietic progenitor cells. Widmer L; Pichert G; Jost LM; Stahel RA Blood; 1996 Oct; 88(8):3166-75. PubMed ID: 8874217 [TBL] [Abstract][Full Text] [Related]
27. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma. Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736 [TBL] [Abstract][Full Text] [Related]
28. Prediction of target CD34 positive cells following leukopheresis in children with neuroblastoma. Schroeder H; Kamperis K; Grunnet N; Hokland P Pediatr Blood Cancer; 2006 Jun; 46(7):786-92. PubMed ID: 16333829 [TBL] [Abstract][Full Text] [Related]
29. A controlled comparison of two different clinical grade devices for CD34+ cell selection of autologous blood stem cell grafts. Björkstrand B; Sundman-Engberg B; Christensson B; Kumlien G J Hematother; 1999 Feb; 8(1):75-80. PubMed ID: 10192304 [TBL] [Abstract][Full Text] [Related]
30. Long-term results of CD34(+) cell transplantation in children with neuroblastoma. Kanold J; Yakouben K; Tchirkov A; Carret AS; Vannier JP; LeGall E; Bordigoni P; Deméocq F Med Pediatr Oncol; 2000 Jul; 35(1):1-7. PubMed ID: 10881000 [TBL] [Abstract][Full Text] [Related]
31. Application of whole blood and peripheral blood progenitor cells (PBPC) and new strategies for rescue after intensive cyclic chemotherapy in high-risk breast cancer. Filip S; Bláha M; Odrázka K; Mericka P; Vávrová J J Hematother Stem Cell Res; 2000 Feb; 9(1):31-8. PubMed ID: 10738969 [TBL] [Abstract][Full Text] [Related]
32. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma. Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456 [TBL] [Abstract][Full Text] [Related]
33. Immunological and molecular detection of tumor contamination in leukapheresis products from children with disseminated neuroblastoma: implication for evaluation of tumor cell depletion after CD34 selection. Tchirkov A; Kanold J; Combaret V; Philip I; Kwiatkowski F; Malet P; Deméocq F Bone Marrow Transplant; 1999 Jul; 24(2):229-30. PubMed ID: 10455360 [No Abstract] [Full Text] [Related]
34. Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction. Mapara MY; Körner IJ; Hildebrandt M; Bargou R; Krahl D; Reichardt P; Dörken B Blood; 1997 Jan; 89(1):337-44. PubMed ID: 8978310 [TBL] [Abstract][Full Text] [Related]
35. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection. Vanásek J; Filip S; Medková V; Bláha M; Mericka P; Volenec K Bone Marrow Transplant; 1998 Jan; 21(2):123-6. PubMed ID: 9489627 [TBL] [Abstract][Full Text] [Related]
36. Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation. Kiss JE; Rybka WB; Winkelstein A; deMagalhaes-Silverman M; Lister J; D'Andrea P; Ball ED Bone Marrow Transplant; 1997 Feb; 19(4):303-10. PubMed ID: 9051238 [TBL] [Abstract][Full Text] [Related]
37. Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system. Di Nicola M; Siena S; Corradini P; Bregni M; Milanesi M; Magni M; Ruffini PA; Ravagnani F; Tarella C; Gianni AM Bone Marrow Transplant; 1996 Dec; 18(6):1117-21. PubMed ID: 8971381 [TBL] [Abstract][Full Text] [Related]
38. Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients: a pilot study. Mapara MY; Körner IJ; Lentzsch S; Krahl D; Reichardt P; Dörken B Exp Hematol; 1999 Jan; 27(1):169-75. PubMed ID: 9923456 [TBL] [Abstract][Full Text] [Related]
39. Breast tumor contamination of PBSC harvests: tumor depletion by positive selection of CD34(+) cells. Burgess J; Mills B; Griffith M; Mansour V; Weaver CH; Schwartzberg LS; Snyder EL; Krause DS; Yanovich S; Prilutskaya M; Umiel T; Moss TJ Cytotherapy; 2001; 3(4):285-94. PubMed ID: 12171717 [TBL] [Abstract][Full Text] [Related]
40. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF. Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]